Fibroid growth and medical options for treatment
- 1 September 2014
- journal article
- review article
- Published by Elsevier BV in Fertility and Sterility
- Vol. 102 (3), 630-639
- https://doi.org/10.1016/j.fertnstert.2014.07.1238
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- The estimated annual cost of uterine leiomyomata in the United StatesAmerican Journal of Obstetrics and Gynecology, 2011
- The selective progesterone receptor modulator CDB4124 inhibits proliferation and induces apoptosis in uterine leiomyoma cellsFertility and Sterility, 2010
- Green tea extract inhibits proliferation of uterine leiomyoma cells in vitro and in nude miceAmerican Journal of Obstetrics and Gynecology, 2010
- Improved quality of life is partly explained by fewer symptoms after treatment of fibroids with mifepristoneInternational Journal of Gynecology & Obstetrics, 2010
- Antiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cellsFertility and Sterility, 2009
- A comparison of methods and results in recruiting white and black women into reproductive studies: The MMC–PSU cooperative center on reproduction experienceContemporary Clinical Trials, 2008
- Differential expression of microRNA species in human uterine leiomyoma versus normal myometriumFertility and Sterility, 2008
- Incidence, aetiology and epidemiology of uterine fibroidsBest Practice & Research Clinical Obstetrics & Gynaecology, 2008
- Mechanical homeostasis is altered in uterine leiomyomaAmerican Journal of Obstetrics and Gynecology, 2008
- Polycystic ovary syndrome and risk of uterine leiomyomataFertility and Sterility, 2007